nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—CYP2A6—Rifampicin—leprosy	0.257	0.353	CbGbCtD
Memantine—CYP2B6—Rifampicin—leprosy	0.167	0.23	CbGbCtD
Memantine—CYP2C19—Thalidomide—leprosy	0.11	0.151	CbGbCtD
Memantine—CYP2C19—Rifampicin—leprosy	0.106	0.146	CbGbCtD
Memantine—CYP2C19—Dapsone—leprosy	0.0876	0.121	CbGbCtD
Memantine—HTR3A—cranial nerve—leprosy	0.00842	0.182	CbGeAlD
Memantine—GRIN2B—nerve—leprosy	0.00744	0.161	CbGeAlD
Memantine—GRIN2A—nerve—leprosy	0.0065	0.141	CbGeAlD
Memantine—Mental status changes—Thalidomide—leprosy	0.00507	0.0224	CcSEcCtD
Memantine—HTR3A—nerve—leprosy	0.00431	0.0932	CbGeAlD
Memantine—Suicide attempt—Dapsone—leprosy	0.00412	0.0182	CcSEcCtD
Memantine—Thromboembolism—Thalidomide—leprosy	0.00376	0.0166	CcSEcCtD
Memantine—Pyuria—Thalidomide—leprosy	0.00342	0.0151	CcSEcCtD
Memantine—Lacrimal disorder—Thalidomide—leprosy	0.00267	0.0118	CcSEcCtD
Memantine—DRD2—nerve—leprosy	0.00264	0.057	CbGeAlD
Memantine—Parkinsonism—Thalidomide—leprosy	0.00263	0.0116	CcSEcCtD
Memantine—Hyporeflexia—Thalidomide—leprosy	0.00263	0.0116	CcSEcCtD
Memantine—Raised liver function tests—Thalidomide—leprosy	0.00259	0.0114	CcSEcCtD
Memantine—Altered state of consciousness—Thalidomide—leprosy	0.00259	0.0114	CcSEcCtD
Memantine—Hernia—Thalidomide—leprosy	0.00255	0.0113	CcSEcCtD
Memantine—Grand mal convulsion—Thalidomide—leprosy	0.00251	0.0111	CcSEcCtD
Memantine—Embolism venous—Thalidomide—leprosy	0.00237	0.0105	CcSEcCtD
Memantine—Transient ischaemic attack—Thalidomide—leprosy	0.00237	0.0105	CcSEcCtD
Memantine—Skin exfoliation—Dapsone—leprosy	0.00223	0.00985	CcSEcCtD
Memantine—Venous thrombosis—Thalidomide—leprosy	0.00222	0.00978	CcSEcCtD
Memantine—Suicide attempt—Thalidomide—leprosy	0.00211	0.00931	CcSEcCtD
Memantine—Gastric ulcer—Thalidomide—leprosy	0.00206	0.00909	CcSEcCtD
Memantine—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.00206	0.00909	CcSEcCtD
Memantine—Toothache—Thalidomide—leprosy	0.00197	0.00868	CcSEcCtD
Memantine—Deep vein thrombosis—Thalidomide—leprosy	0.00197	0.00868	CcSEcCtD
Memantine—GRIN3A—testis—leprosy	0.00189	0.0408	CbGeAlD
Memantine—Embolism—Thalidomide—leprosy	0.00186	0.00823	CcSEcCtD
Memantine—Hypothyroidism—Thalidomide—leprosy	0.00186	0.00823	CcSEcCtD
Memantine—GRIN3A—nervous system—leprosy	0.00185	0.04	CbGeAlD
Memantine—Tooth disorder—Thalidomide—leprosy	0.00184	0.00814	CcSEcCtD
Memantine—GRIN2A—tendon—leprosy	0.0018	0.0389	CbGeAlD
Memantine—GRIN1—nervous system—leprosy	0.00175	0.0379	CbGeAlD
Memantine—Menstrual disorder—Thalidomide—leprosy	0.00175	0.00775	CcSEcCtD
Memantine—Neuralgia—Thalidomide—leprosy	0.00172	0.0076	CcSEcCtD
Memantine—GRIN2B—nervous system—leprosy	0.00167	0.0362	CbGeAlD
Memantine—Hyperlipidaemia—Thalidomide—leprosy	0.00166	0.00733	CcSEcCtD
Memantine—Psychotic disorder—Dapsone—leprosy	0.00166	0.00731	CcSEcCtD
Memantine—Stupor—Thalidomide—leprosy	0.0016	0.00707	CcSEcCtD
Memantine—Skin ulcer—Thalidomide—leprosy	0.00154	0.00678	CcSEcCtD
Memantine—Nasopharyngitis—Dapsone—leprosy	0.00152	0.0067	CcSEcCtD
Memantine—Muscular weakness—Dapsone—leprosy	0.0015	0.0066	CcSEcCtD
Memantine—GRIN2A—testis—leprosy	0.00149	0.0322	CbGeAlD
Memantine—Influenza—Dapsone—leprosy	0.00147	0.00647	CcSEcCtD
Memantine—GRIN2A—nervous system—leprosy	0.00146	0.0316	CbGeAlD
Memantine—Endocrine disorder—Thalidomide—leprosy	0.00144	0.00637	CcSEcCtD
Memantine—Numbness—Thalidomide—leprosy	0.00144	0.00637	CcSEcCtD
Memantine—Pancreatitis—Dapsone—leprosy	0.00144	0.00635	CcSEcCtD
Memantine—Apnoea—Thalidomide—leprosy	0.00141	0.00623	CcSEcCtD
Memantine—Sensory loss—Thalidomide—leprosy	0.00138	0.0061	CcSEcCtD
Memantine—Accidental injury—Thalidomide—leprosy	0.00135	0.00597	CcSEcCtD
Memantine—Bone disorder—Thalidomide—leprosy	0.00132	0.00585	CcSEcCtD
Memantine—Hyperbilirubinaemia—Thalidomide—leprosy	0.00132	0.00581	CcSEcCtD
Memantine—Arthropathy—Thalidomide—leprosy	0.00132	0.00581	CcSEcCtD
Memantine—Cellulitis—Thalidomide—leprosy	0.00132	0.00581	CcSEcCtD
Memantine—Thinking abnormal—Thalidomide—leprosy	0.00131	0.00577	CcSEcCtD
Memantine—Hyperuricaemia—Thalidomide—leprosy	0.00129	0.00569	CcSEcCtD
Memantine—Neuropathy peripheral—Dapsone—leprosy	0.00128	0.00566	CcSEcCtD
Memantine—Dyskinesia—Thalidomide—leprosy	0.00127	0.00562	CcSEcCtD
Memantine—Leukocytosis—Thalidomide—leprosy	0.00127	0.00562	CcSEcCtD
Memantine—Hypercholesterolaemia—Thalidomide—leprosy	0.00126	0.00558	CcSEcCtD
Memantine—Creatinine increased—Thalidomide—leprosy	0.00126	0.00555	CcSEcCtD
Memantine—Hearing impaired—Thalidomide—leprosy	0.00126	0.00555	CcSEcCtD
Memantine—Bone pain—Thalidomide—leprosy	0.00125	0.00551	CcSEcCtD
Memantine—Atrioventricular block—Thalidomide—leprosy	0.00123	0.00544	CcSEcCtD
Memantine—Sinusitis—Dapsone—leprosy	0.00123	0.00541	CcSEcCtD
Memantine—Gait disturbance—Thalidomide—leprosy	0.00123	0.00541	CcSEcCtD
Memantine—Coordination abnormal—Thalidomide—leprosy	0.00122	0.00538	CcSEcCtD
Memantine—Blood uric acid increased—Thalidomide—leprosy	0.00122	0.00538	CcSEcCtD
Memantine—Pulmonary embolism—Thalidomide—leprosy	0.0012	0.00528	CcSEcCtD
Memantine—Phosphatase alkaline increased—Thalidomide—leprosy	0.0012	0.00528	CcSEcCtD
Memantine—Hyperkalaemia—Thalidomide—leprosy	0.00117	0.00519	CcSEcCtD
Memantine—Eructation—Thalidomide—leprosy	0.00117	0.00519	CcSEcCtD
Memantine—Pharyngitis—Dapsone—leprosy	0.00116	0.00514	CcSEcCtD
Memantine—Depressed level of consciousness—Thalidomide—leprosy	0.00115	0.0051	CcSEcCtD
Memantine—Colitis—Thalidomide—leprosy	0.00115	0.00507	CcSEcCtD
Memantine—Candida infection—Thalidomide—leprosy	0.00114	0.00504	CcSEcCtD
Memantine—Skin exfoliation—Thalidomide—leprosy	0.00114	0.00504	CcSEcCtD
Memantine—Blood urea increased—Thalidomide—leprosy	0.00113	0.00499	CcSEcCtD
Memantine—Neuropathy—Thalidomide—leprosy	0.00112	0.00496	CcSEcCtD
Memantine—DRD2—eye—leprosy	0.0011	0.0238	CbGeAlD
Memantine—Tinnitus—Dapsone—leprosy	0.00109	0.00483	CcSEcCtD
Memantine—Oesophagitis—Thalidomide—leprosy	0.00109	0.00483	CcSEcCtD
Memantine—Pulmonary oedema—Thalidomide—leprosy	0.00106	0.0047	CcSEcCtD
Memantine—Hypertonia—Thalidomide—leprosy	0.00105	0.00463	CcSEcCtD
Memantine—Hyperkinesia—Thalidomide—leprosy	0.00104	0.00461	CcSEcCtD
Memantine—Mental disability—Thalidomide—leprosy	0.00104	0.00458	CcSEcCtD
Memantine—Sepsis—Thalidomide—leprosy	0.00104	0.00458	CcSEcCtD
Memantine—Thrombophlebitis—Thalidomide—leprosy	0.001	0.00443	CcSEcCtD
Memantine—Diabetes mellitus—Thalidomide—leprosy	0.000998	0.00441	CcSEcCtD
Memantine—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000998	0.00441	CcSEcCtD
Memantine—Gastroenteritis—Thalidomide—leprosy	0.000979	0.00432	CcSEcCtD
Memantine—Deafness—Thalidomide—leprosy	0.00097	0.00429	CcSEcCtD
Memantine—Vascular purpura—Thalidomide—leprosy	0.00097	0.00429	CcSEcCtD
Memantine—HTR3A—nervous system—leprosy	0.00097	0.021	CbGeAlD
Memantine—Eczema—Thalidomide—leprosy	0.000966	0.00427	CcSEcCtD
Memantine—Vision blurred—Dapsone—leprosy	0.000962	0.00425	CcSEcCtD
Memantine—Eye pain—Thalidomide—leprosy	0.000962	0.00425	CcSEcCtD
Memantine—Cardiac failure congestive—Thalidomide—leprosy	0.000957	0.00423	CcSEcCtD
Memantine—Injury—Thalidomide—leprosy	0.000944	0.00417	CcSEcCtD
Memantine—Renal failure acute—Thalidomide—leprosy	0.00094	0.00415	CcSEcCtD
Memantine—Libido decreased—Thalidomide—leprosy	0.000936	0.00413	CcSEcCtD
Memantine—Amnesia—Thalidomide—leprosy	0.000924	0.00408	CcSEcCtD
Memantine—Increased appetite—Thalidomide—leprosy	0.000924	0.00408	CcSEcCtD
Memantine—Vertigo—Dapsone—leprosy	0.000917	0.00405	CcSEcCtD
Memantine—Atrial fibrillation—Thalidomide—leprosy	0.000916	0.00405	CcSEcCtD
Memantine—Dermatitis bullous—Thalidomide—leprosy	0.000908	0.00401	CcSEcCtD
Memantine—Purpura—Thalidomide—leprosy	0.000901	0.00398	CcSEcCtD
Memantine—Arthritis—Thalidomide—leprosy	0.000893	0.00394	CcSEcCtD
Memantine—Cough—Dapsone—leprosy	0.000891	0.00394	CcSEcCtD
Memantine—Hypoglycaemia—Thalidomide—leprosy	0.000889	0.00393	CcSEcCtD
Memantine—Cardiac failure—Thalidomide—leprosy	0.000889	0.00393	CcSEcCtD
Memantine—Lethargy—Thalidomide—leprosy	0.000886	0.00391	CcSEcCtD
Memantine—Cerebrovascular accident—Thalidomide—leprosy	0.000886	0.00391	CcSEcCtD
Memantine—Hyponatraemia—Thalidomide—leprosy	0.000872	0.00385	CcSEcCtD
Memantine—Osteoarthritis—Thalidomide—leprosy	0.000868	0.00383	CcSEcCtD
Memantine—Diplopia—Thalidomide—leprosy	0.000868	0.00383	CcSEcCtD
Memantine—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000868	0.00383	CcSEcCtD
Memantine—Pain in extremity—Thalidomide—leprosy	0.000868	0.00383	CcSEcCtD
Memantine—Disturbance in sexual arousal—Thalidomide—leprosy	0.000861	0.0038	CcSEcCtD
Memantine—Affect lability—Thalidomide—leprosy	0.000854	0.00377	CcSEcCtD
Memantine—Psychotic disorder—Thalidomide—leprosy	0.000848	0.00374	CcSEcCtD
Memantine—Cardiac arrest—Thalidomide—leprosy	0.000825	0.00365	CcSEcCtD
Memantine—Mood swings—Thalidomide—leprosy	0.000822	0.00363	CcSEcCtD
Memantine—Ataxia—Thalidomide—leprosy	0.000816	0.0036	CcSEcCtD
Memantine—Tachycardia—Dapsone—leprosy	0.000813	0.00359	CcSEcCtD
Memantine—Blood creatinine increased—Thalidomide—leprosy	0.000813	0.00359	CcSEcCtD
Memantine—Dehydration—Thalidomide—leprosy	0.000807	0.00356	CcSEcCtD
Memantine—Liver function test abnormal—Thalidomide—leprosy	0.000801	0.00354	CcSEcCtD
Memantine—Dry skin—Thalidomide—leprosy	0.000796	0.00351	CcSEcCtD
Memantine—Orthostatic hypotension—Thalidomide—leprosy	0.000793	0.0035	CcSEcCtD
Memantine—Hypokalaemia—Thalidomide—leprosy	0.00079	0.00349	CcSEcCtD
Memantine—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000782	0.00345	CcSEcCtD
Memantine—CYP2B6—skin of body—leprosy	0.000776	0.0168	CbGeAlD
Memantine—Muscular weakness—Thalidomide—leprosy	0.000766	0.00338	CcSEcCtD
Memantine—Alanine aminotransferase increased—Thalidomide—leprosy	0.000766	0.00338	CcSEcCtD
Memantine—Insomnia—Dapsone—leprosy	0.000754	0.00333	CcSEcCtD
Memantine—Dysphagia—Thalidomide—leprosy	0.00075	0.00331	CcSEcCtD
Memantine—Influenza—Thalidomide—leprosy	0.00075	0.00331	CcSEcCtD
Memantine—Bronchospasm—Thalidomide—leprosy	0.000738	0.00326	CcSEcCtD
Memantine—Pancreatitis—Thalidomide—leprosy	0.000736	0.00325	CcSEcCtD
Memantine—Angina pectoris—Thalidomide—leprosy	0.000731	0.00323	CcSEcCtD
Memantine—Bronchitis—Thalidomide—leprosy	0.000722	0.00319	CcSEcCtD
Memantine—Pancytopenia—Thalidomide—leprosy	0.000712	0.00315	CcSEcCtD
Memantine—Neutropenia—Thalidomide—leprosy	0.000702	0.0031	CcSEcCtD
Memantine—Upper respiratory tract infection—Thalidomide—leprosy	0.000697	0.00308	CcSEcCtD
Memantine—Pollakiuria—Thalidomide—leprosy	0.000693	0.00306	CcSEcCtD
Memantine—Erectile dysfunction—Thalidomide—leprosy	0.000691	0.00305	CcSEcCtD
Memantine—Weight increased—Thalidomide—leprosy	0.000683	0.00302	CcSEcCtD
Memantine—Gastrointestinal pain—Dapsone—leprosy	0.000681	0.00301	CcSEcCtD
Memantine—Weight decreased—Thalidomide—leprosy	0.000679	0.003	CcSEcCtD
Memantine—Hyperglycaemia—Thalidomide—leprosy	0.000677	0.00299	CcSEcCtD
Memantine—Pneumonia—Thalidomide—leprosy	0.000673	0.00297	CcSEcCtD
Memantine—Infestation NOS—Thalidomide—leprosy	0.000669	0.00295	CcSEcCtD
Memantine—Infestation—Thalidomide—leprosy	0.000669	0.00295	CcSEcCtD
Memantine—Depression—Thalidomide—leprosy	0.000667	0.00295	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000663	0.00293	CcSEcCtD
Memantine—Acute coronary syndrome—Thalidomide—leprosy	0.000659	0.00291	CcSEcCtD
Memantine—Abdominal pain—Dapsone—leprosy	0.000659	0.00291	CcSEcCtD
Memantine—Body temperature increased—Dapsone—leprosy	0.000659	0.00291	CcSEcCtD
Memantine—Renal failure—Thalidomide—leprosy	0.000658	0.0029	CcSEcCtD
Memantine—Myocardial infarction—Thalidomide—leprosy	0.000656	0.0029	CcSEcCtD
Memantine—Neuropathy peripheral—Thalidomide—leprosy	0.000656	0.0029	CcSEcCtD
Memantine—Conjunctivitis—Thalidomide—leprosy	0.00065	0.00287	CcSEcCtD
Memantine—Haematuria—Thalidomide—leprosy	0.000638	0.00282	CcSEcCtD
Memantine—Epistaxis—Thalidomide—leprosy	0.000631	0.00279	CcSEcCtD
Memantine—Sinusitis—Thalidomide—leprosy	0.000628	0.00277	CcSEcCtD
Memantine—Agranulocytosis—Thalidomide—leprosy	0.000624	0.00276	CcSEcCtD
Memantine—Bradycardia—Thalidomide—leprosy	0.000611	0.0027	CcSEcCtD
Memantine—DRD2—testis—leprosy	0.000605	0.0131	CbGeAlD
Memantine—Rhinitis—Thalidomide—leprosy	0.000602	0.00266	CcSEcCtD
Memantine—Hepatitis—Thalidomide—leprosy	0.000601	0.00265	CcSEcCtD
Memantine—Hypoaesthesia—Thalidomide—leprosy	0.000597	0.00264	CcSEcCtD
Memantine—Pharyngitis—Thalidomide—leprosy	0.000596	0.00263	CcSEcCtD
Memantine—DRD2—nervous system—leprosy	0.000593	0.0128	CbGeAlD
Memantine—Urinary tract disorder—Thalidomide—leprosy	0.000593	0.00262	CcSEcCtD
Memantine—Oedema peripheral—Thalidomide—leprosy	0.000592	0.00261	CcSEcCtD
Memantine—Urethral disorder—Thalidomide—leprosy	0.000589	0.0026	CcSEcCtD
Memantine—Visual impairment—Thalidomide—leprosy	0.000579	0.00256	CcSEcCtD
Memantine—Erythema multiforme—Thalidomide—leprosy	0.000568	0.00251	CcSEcCtD
Memantine—Eye disorder—Thalidomide—leprosy	0.000561	0.00248	CcSEcCtD
Memantine—Tinnitus—Thalidomide—leprosy	0.00056	0.00247	CcSEcCtD
Memantine—Cardiac disorder—Thalidomide—leprosy	0.000557	0.00246	CcSEcCtD
Memantine—Angiopathy—Thalidomide—leprosy	0.000545	0.00241	CcSEcCtD
Memantine—Immune system disorder—Thalidomide—leprosy	0.000542	0.0024	CcSEcCtD
Memantine—Mediastinal disorder—Thalidomide—leprosy	0.000541	0.00239	CcSEcCtD
Memantine—Chills—Thalidomide—leprosy	0.000539	0.00238	CcSEcCtD
Memantine—Arrhythmia—Thalidomide—leprosy	0.000536	0.00237	CcSEcCtD
Memantine—Alopecia—Thalidomide—leprosy	0.000531	0.00234	CcSEcCtD
Memantine—Vomiting—Dapsone—leprosy	0.00053	0.00234	CcSEcCtD
Memantine—Mental disorder—Thalidomide—leprosy	0.000526	0.00232	CcSEcCtD
Memantine—Malnutrition—Thalidomide—leprosy	0.000523	0.00231	CcSEcCtD
Memantine—Headache—Dapsone—leprosy	0.000522	0.00231	CcSEcCtD
Memantine—Flatulence—Thalidomide—leprosy	0.000515	0.00227	CcSEcCtD
Memantine—Tension—Thalidomide—leprosy	0.000513	0.00227	CcSEcCtD
Memantine—Dysgeusia—Thalidomide—leprosy	0.000512	0.00226	CcSEcCtD
Memantine—Nervousness—Thalidomide—leprosy	0.000508	0.00224	CcSEcCtD
Memantine—Back pain—Thalidomide—leprosy	0.000506	0.00223	CcSEcCtD
Memantine—Nausea—Dapsone—leprosy	0.000495	0.00219	CcSEcCtD
Memantine—Vision blurred—Thalidomide—leprosy	0.000493	0.00218	CcSEcCtD
Memantine—Tremor—Thalidomide—leprosy	0.00049	0.00216	CcSEcCtD
Memantine—CYP2B6—testis—leprosy	0.000489	0.0106	CbGeAlD
Memantine—Ill-defined disorder—Thalidomide—leprosy	0.000485	0.00214	CcSEcCtD
Memantine—Anaemia—Thalidomide—leprosy	0.000483	0.00213	CcSEcCtD
Memantine—Agitation—Thalidomide—leprosy	0.00048	0.00212	CcSEcCtD
Memantine—CYP2B6—nervous system—leprosy	0.00048	0.0104	CbGeAlD
Memantine—Malaise—Thalidomide—leprosy	0.000471	0.00208	CcSEcCtD
Memantine—Vertigo—Thalidomide—leprosy	0.00047	0.00207	CcSEcCtD
Memantine—Syncope—Thalidomide—leprosy	0.000469	0.00207	CcSEcCtD
Memantine—Leukopenia—Thalidomide—leprosy	0.000468	0.00207	CcSEcCtD
Memantine—Palpitations—Thalidomide—leprosy	0.000462	0.00204	CcSEcCtD
Memantine—Loss of consciousness—Thalidomide—leprosy	0.000459	0.00203	CcSEcCtD
Memantine—Cough—Thalidomide—leprosy	0.000456	0.00201	CcSEcCtD
Memantine—Convulsion—Thalidomide—leprosy	0.000453	0.002	CcSEcCtD
Memantine—Hypertension—Thalidomide—leprosy	0.000451	0.00199	CcSEcCtD
Memantine—Arthralgia—Thalidomide—leprosy	0.000445	0.00197	CcSEcCtD
Memantine—Myalgia—Thalidomide—leprosy	0.000445	0.00197	CcSEcCtD
Memantine—Chest pain—Thalidomide—leprosy	0.000445	0.00197	CcSEcCtD
Memantine—Anxiety—Thalidomide—leprosy	0.000444	0.00196	CcSEcCtD
Memantine—Discomfort—Thalidomide—leprosy	0.00044	0.00194	CcSEcCtD
Memantine—Dry mouth—Thalidomide—leprosy	0.000435	0.00192	CcSEcCtD
Memantine—Confusional state—Thalidomide—leprosy	0.00043	0.0019	CcSEcCtD
Memantine—Oedema—Thalidomide—leprosy	0.000427	0.00188	CcSEcCtD
Memantine—Infection—Thalidomide—leprosy	0.000424	0.00187	CcSEcCtD
Memantine—Shock—Thalidomide—leprosy	0.00042	0.00185	CcSEcCtD
Memantine—Nervous system disorder—Thalidomide—leprosy	0.000418	0.00185	CcSEcCtD
Memantine—Thrombocytopenia—Thalidomide—leprosy	0.000418	0.00184	CcSEcCtD
Memantine—Tachycardia—Thalidomide—leprosy	0.000416	0.00184	CcSEcCtD
Memantine—Skin disorder—Thalidomide—leprosy	0.000414	0.00183	CcSEcCtD
Memantine—Hyperhidrosis—Thalidomide—leprosy	0.000412	0.00182	CcSEcCtD
Memantine—Anorexia—Thalidomide—leprosy	0.000407	0.0018	CcSEcCtD
Memantine—Hypotension—Thalidomide—leprosy	0.000399	0.00176	CcSEcCtD
Memantine—Musculoskeletal discomfort—Thalidomide—leprosy	0.000389	0.00172	CcSEcCtD
Memantine—Insomnia—Thalidomide—leprosy	0.000386	0.0017	CcSEcCtD
Memantine—Paraesthesia—Thalidomide—leprosy	0.000383	0.00169	CcSEcCtD
Memantine—Dyspnoea—Thalidomide—leprosy	0.00038	0.00168	CcSEcCtD
Memantine—Somnolence—Thalidomide—leprosy	0.000379	0.00167	CcSEcCtD
Memantine—Dyspepsia—Thalidomide—leprosy	0.000376	0.00166	CcSEcCtD
Memantine—Decreased appetite—Thalidomide—leprosy	0.000371	0.00164	CcSEcCtD
Memantine—Gastrointestinal disorder—Thalidomide—leprosy	0.000368	0.00163	CcSEcCtD
Memantine—Fatigue—Thalidomide—leprosy	0.000368	0.00162	CcSEcCtD
Memantine—Pain—Thalidomide—leprosy	0.000365	0.00161	CcSEcCtD
Memantine—Constipation—Thalidomide—leprosy	0.000365	0.00161	CcSEcCtD
Memantine—Feeling abnormal—Thalidomide—leprosy	0.000352	0.00155	CcSEcCtD
Memantine—Gastrointestinal pain—Thalidomide—leprosy	0.000349	0.00154	CcSEcCtD
Memantine—Urticaria—Thalidomide—leprosy	0.000339	0.0015	CcSEcCtD
Memantine—Abdominal pain—Thalidomide—leprosy	0.000337	0.00149	CcSEcCtD
Memantine—Body temperature increased—Thalidomide—leprosy	0.000337	0.00149	CcSEcCtD
Memantine—Hypersensitivity—Thalidomide—leprosy	0.000314	0.00139	CcSEcCtD
Memantine—Asthenia—Thalidomide—leprosy	0.000306	0.00135	CcSEcCtD
Memantine—Pruritus—Thalidomide—leprosy	0.000302	0.00133	CcSEcCtD
Memantine—Diarrhoea—Thalidomide—leprosy	0.000292	0.00129	CcSEcCtD
Memantine—Dizziness—Thalidomide—leprosy	0.000282	0.00125	CcSEcCtD
Memantine—Vomiting—Thalidomide—leprosy	0.000271	0.0012	CcSEcCtD
Memantine—Rash—Thalidomide—leprosy	0.000269	0.00119	CcSEcCtD
Memantine—Dermatitis—Thalidomide—leprosy	0.000269	0.00119	CcSEcCtD
Memantine—Headache—Thalidomide—leprosy	0.000267	0.00118	CcSEcCtD
Memantine—Nausea—Thalidomide—leprosy	0.000253	0.00112	CcSEcCtD
